Covered recipient · General Payments record
JENNIFER L BOWERMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,209.03
- Reported across 228 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $583.14 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $169.17 | 12 |
| Acerta Pharma LLC | $55.41 | 3 |
| Amgen Inc. | $50.24 | 2 |
| Inspire Medical Systems, Inc. | $47.42 | 1 |
| DEXCOM, INC. | $45.20 | 2 |
| Lilly USA, LLC | $43.49 | 2 |
| Novo Nordisk AS | $37.52 | 2 |
| PFIZER INC. | $29.17 | 2 |
| Daiichi Sankyo Inc. | $24.27 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.84 | 1 |
| Merck Sharp & Dohme Corporation | $17.48 | 1 |
| Exact Sciences Corporation | $17.43 | 1 |
| Astellas Pharma US Inc | $13.38 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.66 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356024 | CMS |
| ABBVIE INC. | $1.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356026 | CMS |
| ABBVIE INC. | $6.85 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356028 | CMS |
| ABBVIE INC. | $5.25 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356030 | CMS |
| ABBVIE INC. | $20.40 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356032 | CMS |
| ABBVIE INC. | $24.09 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356034 | CMS |
| ABBVIE INC. | $3.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356036 | CMS |
| ABBVIE INC. | $3.04 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356038 | CMS |
| ABBVIE INC. | $21.52 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356040 | CMS |
| ABBVIE INC. | $20.10 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356042 | CMS |
| ABBVIE INC. | $26.21 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356044 | CMS |
| ABBVIE INC. | $13.72 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103356046 | CMS |
| Amgen Inc. | $29.87 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111534580 | CMS |
| Amgen Inc. | $20.37 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111534582 | CMS |
| Astellas Pharma US Inc | $13.38 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139397427 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.37 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105541797 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.02 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105700672 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.02 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105615935 | CMS |
| Daiichi Sankyo Inc. | $24.27 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089402161 | CMS |
| Dexcom, Inc. | $23.14 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153307857 | CMS |
| Dexcom, Inc. | $22.06 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153307859 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.12 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101634373 | CMS |
| Exact Sciences Corporation | $17.43 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134957583 | CMS |
| Inspire Medical Systems, Inc. | $47.42 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148044158 | CMS |
| Lilly USA, LLC | $19.28 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135059294 | CMS |
| Lilly USA, LLC | $24.21 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135062407 | CMS |
| Merck Sharp & Dohme LLC | $17.48 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141946979 | CMS |
| Novo Nordisk Inc | $14.57 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097241073 | CMS |
| Novo Nordisk Inc | $22.95 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096851174 | CMS |
| PFIZER INC. | $13.29 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131060539 | CMS |
| PFIZER INC. | $15.88 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131137982 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.84 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144598468 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.